TAVR vs. SAVR in Patients With Severe Aortic Stenosis and Chronic Kidney Disease Undergoing Dialysis: A Comprehensive Meta‐Analysis
Cardiology Research and Practice · 2026-01 · 2026 (1)
DOI: 10.1155/crp/9451268 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiology Research and Practice, online erschienen am 19.06.2026. Verfasst von Maneeth Mylavarapu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Endeavor Health Cardiovascular Institute, Endeavor Health Glenbrook Hospital, Glenview, Illinois, 60026, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Patients with chronic kidney disease (CKD) undergoing dialysis who also suffer from severe aortic stenosis (AS) present a complex management challenge. Both transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) are treatment options, but comparative outcomes in this specific, high‐risk population continue to remain unclear.
Aim
This study aims to compare TAVR and SAVR postoperative clinical outcomes in patients with severe AS and CKD undergoing dialysis.
Methods
According to PRISMA guidelines, a comprehensive search was conducted across various databases such as PubMed, EMBASE, Scopus, and Google Scholar. Original studies that compared the clinical outcomes between TAVR and SAVR in patients with severe AS and CKD undergoing dialysis were included in the study.
Results
Ten studies, all retrospective, involving 28,625 (14,625 TAVR and 14,000 SAVR) patients with severe AS and CKD undergoing dialysis who underwent TAVR or SAVR were included in this study. Patients who underwent TAVR had significantly lower odds of in‐hospital mortality (OR 0.49; 0.29, 0.84; p = 0.01) and shorter length of stay (LOS) (SMD −2.59; 95% CI −5.04, −0.14; p ≤ 0.04). However, the TAVR group had significantly higher odds of permanent pacemaker implantation (OR 2.25; 95% CI 1.71–2.94; p < 0.00001).
Conclusion
In patients with severe AS and CKD undergoing dialysis, TAVR is associated with lower in‐hospital mortality and shorter LOS, suggesting a favorable early safety profile and recovery in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Endeavor Health Cardiovascular Institute, Endeavor Health Glenbrook Hospital, Glenview, Illinois, 60026, USA.
- Division of Cardiology, Department of Medicine, University of Chicago Pritzker School of Medicine, Chicago, Illinois, 60637, USA, uchicago.edu.
- Department of Internal Medicine, MedStar Health, Georgetown University, Washington, District of Columbia, 20007, USA, georgetown.edu.
- Department of Internal Medicine, Advocate Illinois Masonic Medical Center, Chicago, Illinois, 60657, USA, advocatehealth.com.
- Department of Internal Medicine, Mysore Medical College & Research Institute, Mysuru, Karnataka, 570001, India, mysoremedicalcollege.com.
- Department of Family Medicine, University of Southern California School of Medicine, Los Angeles, California, 90033, USA, usc.edu.
ORCID-Profile: Maneeth Mylavarapu, Meghana Reddy, Israel Garcia
Zitieren
APA
Mylavarapu, M., Kiyani, M., Tanwar, N., Reddy, M., Garcia, I., Karnan, N., Rao, N. L., Kodali, L. S. M., & Borra, N. (2026). TAVR vs. SAVR in Patients With Severe Aortic Stenosis and Chronic Kidney Disease Undergoing Dialysis: A Comprehensive Meta‐Analysis. Cardiology Research and Practice, 2026(1). https://doi.org/10.1155/crp/9451268
Vancouver
Mylavarapu M, Kiyani M, Tanwar N, Reddy M, Garcia I, Karnan N, et al. TAVR vs. SAVR in Patients With Severe Aortic Stenosis and Chronic Kidney Disease Undergoing Dialysis: A Comprehensive Meta‐Analysis. Cardiology Research and Practice. 2026;2026(1). doi:10.1155/crp/9451268
BibTeX
@article{Mylavarapu2026,
author = {Mylavarapu, Maneeth and Kiyani, Madiha and Tanwar, Niharika and Reddy, Meghana and Garcia, Israel and Karnan, Nithin and Rao, Nidhi Laxminarayan and Kodali, Lakshmi Sai Meghana and Borra, Nimisha},
title = {TAVR vs. SAVR in Patients With Severe Aortic Stenosis and Chronic Kidney Disease Undergoing Dialysis: A Comprehensive Meta‐Analysis},
journal = {Cardiology Research and Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/crp/9451268}
}
EUVIMED